Peter van Schijndel

Peter is part of the team that founded HOYNG ROKH MONEGIER in 2011. He made partner in 2017. He specializes in patent litigation, with a particular focus on the pharmaceutical, biotech and medical devices industry. Most of Peter’s cases have an international dimension, and he has extensive experience in coordinating multi-jurisdictional IP matters.

Representative clients in the pharmaceutical / biotechnology field include AbbVie, Abbott, Biogen, Johnson & Johnson, Gilead, Sanofi, Pfizer, UCB, and Regeneron.

In addition to his practice as a lawyer, Peter is a member of the IP faculty of the University of Leiden where he coordinates and teaches a full term course on patent law.

Peter has registered Intellectual Property Law as his principal legal practice area in the Netherlands Bar’s register of legal practice areas (rechtsgebiedenregister). Based on this registration, he is required to obtain ten training credits per calendar year in this principal legal practice area in accordance with the standards set by the Netherlands Bar.